表紙:ラボオンチップの世界市場:予測(2022年~2028年)
市場調査レポート
商品コード
1123142

ラボオンチップの世界市場:予測(2022年~2028年)

Global Lab-On-a-Chip Market Research and Forecast, 2022-2028

出版日: | 発行: Orion Market Research | ページ情報: 英文 120 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
ラボオンチップの世界市場:予測(2022年~2028年)
出版日: 2022年07月23日
発行: Orion Market Research
ページ情報: 英文 120 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のラボオンチップ(LOC)の市場規模は、予測期間(2021年~2027年)に9.3%のCAGRで拡大すると予測されています。同市場の成長を促進する要因には、医療産業におけるラボオンチップデバイスの広範な使用などがあります。さらに、診断における応答時間の短縮、液量消費の削減、学術・研究機関での使用なども、市場の成長促進要因となっています。

当レポートでは、世界のラボオンチップ市場について調査し、市場の概要とともに、製品タイプ別、用途別、技術別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 レポートの概要

第2章 市場概要と洞察

第3章 競合情勢

  • 主要企業分析
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の開発
  • 主要戦略分析
  • COVID-19が主要参入企業に与える影響

第4章 市場決定要因

  • 促進要因
  • 抑制要因
  • 機会

第5章 市場セグメンテーション

  • 世界のラボオンチップ市場、製品タイプ別
    • 試薬と消耗品
    • 装置
  • 世界のラボオンチップ市場、用途別
    • ゲノミクス
    • プロテオミクス
    • 診断
    • 創薬
  • 世界のラボオンチップ市場、技術別
    • DNAマイクロアレイ
    • マイクロ流体チップ
  • 世界のラボオンチップ市場、エンドユーザー別
    • 病院、診断試験所
    • 製薬会社
    • 個人

第6章 地域分析

  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第7章 企業プロファイル

  • 1DROP Diagnostics
  • Abbott Laboratories
  • Adhesives Research, Inc.
  • Agilent Technologies, Inc.
  • Axxicon Moulds Eindhoven B.V.
  • BioFluidix GmbH
  • BioForce Nanosciences, Inc.
  • Bio-Rad Laboratories, Inc.
  • BluSense Diagnostics, Inc.
  • Beckman Coulter, Inc.(CytoFluidix)
  • Danaher Corp.
  • F. Hoffmann-La Roche AG
  • Fluidigm Corp.
  • Fluxion Biosciences, Inc.
  • Genalyte, Inc.
  • HiComp Microtech(Suzhou)Co. Ltd.
  • IDEX Corp.
  • Illumina, Inc
  • LabSmith, Inc.
  • Micralyne, Inc.
  • PerkinElmer Inc.
  • RheoSense, Inc.
  • Siemens Healthcare GmbH
  • Syrris Ltd.
  • Thermo Fisher Scientific Inc.
  • ZenLeads, Inc.
  • Zepto Life Technology, LLC
図表

LIST OF TABLES

1. GLOBAL LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION).

2. GLOBAL LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION).

3. GLOBAL REAGENTS & CONSUMABLE FOR LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION).

4. GLOBAL INSTRUMENTS FOR LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION).

5. GLOBAL LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION).

6. GLOBAL LAB-ON-A-CHIP IN GENOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION).

7. GLOBAL LAB-ON-A-CHIP IN PROTEOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION).

8. GLOBAL LAB-ON-A-CHIP IN DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION).

9. GLOBAL LAB-ON-A-CHIP IN DRUG DISCOVERY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION).

10. GLOBAL LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION).

11. GLOBAL DNA MICROARRAYS IN LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION).

12. GLOBAL MICROFLUIDICS CHIP IN LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION).

13. GLOBAL LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION).

14. GLOBAL LAB-ON-A-CHIP IN HOSPITAL AND DIAGNOSTIC LABS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION).

15. GLOBAL LAB-ON-A-CHIP IN PHARMACEUTICAL COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION).

16. GLOBAL LAB-ON-A-CHIP IN INDIVIDUALS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION).

  • 17. NORTH AMERICAN LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)

18. NORTH AMERICAN LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION).

19. NORTH AMERICAN LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION).

20. NORTH AMERICAN LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION).

21. NORTH AMERICAN LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION).

22. EUROPEAN LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION).

23. EUROPEAN LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION).

24. EUROPEAN LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION).

25. EUROPEAN LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION).

26. EUROPE LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION).

27. ASIA PACIFIC LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION).

28. ASIA PACIFIC LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION).

29. ASIA PACIFIC LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION).

30. ASIA PACIFIC LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION).

31. ASIA PACIFIC LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION).

  • 32. REST OF THE WORLD LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
  • 33. REST OF THE WORLD LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 34. REST OF THE WORLD LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
  • 35. REST OF THE WORLD LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL LAB-ON-A-CHIP MARKET, 2020-2027 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL LAB-ON-A-CHIP MARKET BY SEGMENT, 2020-2027 ($ MILLION)
  • 3. RECOVERY OF GLOBAL LAB-ON-A-CHIP MARKET, 2021-2027 (%)

4. GLOBAL LAB-ON-A-CHIP MARKET SHARE BY PRODUCT TYPE, 2020 VS 2027 (IN %)

5. GLOBAL LAB-ON-A-CHIP MARKET SHARE BY APPLICATION, 2020 VS 2027 (IN %)

6. GLOBAL LAB-ON-A-CHIP MARKET SHARE BY TECHNOLOGY, 2020 VS 2027 (IN %)

7. GLOBAL LAB-ON-A-CHIP MARKET SHARE BY END-USER, 2020 VS 2027 (IN %)

  • 8. GLOBAL REAGENTS & CONSUMABLE FOR LAB-ON-A-CHIP MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 9. GLOBAL INSTRUMENTS FOR LAB-ON-A-CHIP MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 10. GLOBAL LAB-ON-A-CHIP IN GENOMICS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 11. GLOBAL LAB-ON-A-CHIP IN PROTEOMICS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 12. GLOBAL LAB-ON-A-CHIP IN DIAGNOSTICS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 13. GLOBAL LAB-ON-A-CHIP IN DRUG DISCOVERY MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 14. GLOBAL DNA MICROARRAYS IN LAB-ON-A-CHIP MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 15. GLOBAL MICROFLUIDICS CHIP IN LAB-ON-A-CHIP MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 16. GLOBAL LAB-ON-A-CHIP IN HOSPITAL AND DIAGNOSTIC LABS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 17. GLOBAL LAB-ON-A-CHIP IN PHARMACEUTICAL COMPANIES MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 18. GLOBAL LAB-ON-A-CHIP IN INDIVIDUALS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 19. US LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS 2020-2027 ($ MILLION)
  • 20. CANADA LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS 2020-2027 ($ MILLION)
  • 21. UK LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)
  • 22. GERMANY LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)
  • 23. SPAIN LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)
  • 24. FRANCE LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)
  • 25. ITALY LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)
  • 26. REST OF EUROPE LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)
  • 27. INDIA LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)
  • 28. CHINA LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)
  • 29. JAPAN LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)
  • 30. SOUTH-KOREA LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)
  • 31. REST OF ASIA PACIFIC REGION LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)
  • 32. REST OF THE WORLD LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)

Choose License Type

Single user $4500, $3375 Multi user $6000, $4500

100% Secured Payment

SHARE ON:

Benefits Of Buying From Us

Covers more than 15 major industries, which are further segmented into 90+ sectors

65% of our clients are loyal customers

120+ countries are covered in analysis

currently servicing 1000+ customers globally

100+ paid data sources mined to research

Our expert team will assist you with all research need and customization

Our expert research analyst will resolve your every query before and after purchasing the report

Related Reports

Cancer Stem Cells (CSCs) Market

Hematopoietic Stem Cell Transplantation Market

Gene Therapy Products Market

In Vivo Toxicology Market

Veterinary Reference Laboratory Market

Microfluidics Market

目次
Product Code: OMR2018251

Global Lab-on-a-Chip Market Size, Share & Trends Analysis Report By Product Type (Reagents & Consumable, and Instruments), By Application (Genomics, Proteomics, Diagnostics, and Drug Discovery), By Technology (DNA Microarrays, and Microfluids Chip), By End-User (Hospitals and Diagnostic Labs, Pharmaceutical Companies, and Individuals) Forecast, 2021-2027

The global Lab-on-a-Chip (LOC) market is growing at a considerable CAGR of 9.3% during the forecast period (2021-2027). The factors that augment the market growth include the extensive use of lab-on-a-chip devices in the medical industry. Moreover, short response time and low fluid volume consumption in diagnosis, and use in academic and research institutes are the other factors that contribute to the growth of the market. In addition to this, easy portability, advancing fabrication technology, and use for biomarker-based identification and early detection of oral cancer have also fueled the demand for LOC's. The rise in chronic diseases across the globe has led to the need for new less time-consuming LOC's. Increasing support from the semiconductor industry in launching innovative circuits for the medical sector is fostering the market growth.

However, the high initial cost of lab-on-a-chip, complex manufacturing, and lack of awareness for the use of LOC's in the developing and undeveloped countries are some of the constraints which are expected to challenge the growth of the market in the forecast period. The limited technical knowledge and availability of alternative technologies are the factors that restrict the market growth. Conversely, rising demand for new technologies from the global market players which results in faster analysis and response times and an increase in the need for diagnosis are some of the opportunities estimated for the market players. For instance, according to reports of the World Health Organization, around 11 million patients with cancer will be diagnosed each year till 2030. Moreover, in August 2019, scientists at Harvard combined organ-on-a-chip and stem-cell technologies to make a tool for diabetes research and beta-cell transplantation which will help scientists for screening insulin-producing cells before transplanting them into a patient.

Impact of COVID-19 on the Global Lab-on-a-Chip Market

The global lab-on-a-chip market had a positive impact on the COVID-19 pandemic in December 2019. The outbreak of COVID-19 in the major economies has increased the manufacturing and supply of Lab-on-a-chip products across the globe which increased market share. This was mainly due to the need for a faster COVID-19 antibody test as it helps to identify the presence of COVID-19 antibodies in blood donors with greater speed and efficiency than the current standard technologies like enzyme-linked immunosorbent assay or ELISA technology. For instance, a lab on a chip developed by the scientists of U-M and CDI can provide a COVID test within 15 minutes. More research in this field is further estimated to have an impact in both saving lives and costs during the global pandemic

Segmental Outlook

The market is segmented based on product type, application, technology, and end-user. Based on the product type segment, the market is segmented into reagents and consumables, and instruments. Among these, the instruments and reagents and consumables segments are anticipated to experience rapid growth soon owing to a surge in demand for lab-on-a-chip technology in both developed and emerging markets. Based on the application segment, the market is segmented into genomics, proteomics, diagnostics, and drug discovery. Based on the technology segment, the market is segmented into DNA microarrays and microfluidic chips. Further, based on the end-user segment, the market is bifurcated into hospitals and diagnostic labs, pharmaceutical companies, and individuals.

Global Lab-on-a-Chip Market Share by Application, 2020 (%)

Global Lab-on-a-Chip Market Share by Application

Diagnostics Segment to Hold a Lucrative Share in the Global Lab-on-a-Chip market

Amongst the application segment of the global lab-on-a-chip market, the diagnostic segment held one of the largest shares in the application segment of the lab-on-a-chip market in 2020. The factors that contributed to the growth of this segment include a rise in the population of patients across the globe which leads to the monitoring of several chronic diseases. Moreover, most of the market players engaged in the development of new and technologically advanced diagnostic tests due to the need for screening of COVID-19 patients. In addition to this, the use of biochips in cancer treatment and diagnostics, the growth in demand for personalized medicines, and use in Point-of-care testing diagnosis and handheld diagnostics are some of the other factors that contribute to the growth of the diagnostic segment. The genomics and Proteomics segment is also estimated to have a significant share owing to opportunities for DNA & RNA sequencing and ultra-high-resolution studies of DNA. Lab-on-a-chip used for genomics is generally of low cost. In a drug discovery segment, LOCs are generally used to generate new knowledge on biological building blocks or to immobilize, transport, and manipulate particles.

Regional Outlooks

The lab-on-a-chip market is analyzed based on the geographical regions that are contributing significantly towards the growth of the market. Based on the geography, the market is segmented into North America (the US and Canada), Europe (Germany, Spain, Italy, France, the UK, and the Rest of Europe), Asia-Pacific (India, China, Japan South Korea, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East and Africa, and Latin America). North America region is estimated to have one of the largest shares in this market. The presence of major market players, government funding for research, high prevalence of chronic diseases, and increase rate of diagnostic tests for the various viral and pathogenic diseases in developed nations like the US and Canada are some of the factors that fuel the growth of the market in the region. For instance, according to the Centers for Disease Control and Prevention in 2020, the number of tuberculosis and salmonella cases were 7,163 and 1.35 million respectively in the U.S. Europe is also estimated to have a significant share in the market owing to the presence of high healthcare infrastructure and clinical researches.

Global Lab-on-a-Chip Market, by Region 2021-2027

Global Lab-on-a-Chip Market Share by region

Asia-Pacific is projected to highest Contributor to the growth of the Global Lab-on-a-Chip market

The Asia-Pacific region is estimated to be one of the fastest-growing regions owing to the increase in the prevalence of infectious diseases, increase in population in the countries such as China and India, and government support to advance healthcare facilities. China is also investing heavily in scientific research to better understand people's biological make-up, as well as analytical tools, cutting-edge data collecting, and efficient computing capabilities, to facilitate a significant volume of research data in the Asia-Pacific region. The country is also a technological leader, particularly in the lab-on-a-chip-based POC. As a result, dominating growth factor of the market is a growing focus on clinical research, precision medicine, technology advancements, and new drug discovery.

Market Player Outlook

The key players of the lab-on-a-chip market include Agilent Technologies, Inc., Siemens AG, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Beckman Coulter, Inc. (CytoFluidix), Abbott Laboratories, Inc., Thermo Fisher Scientific Inc., and Danaher Corp., among others. These key manufacturers are adopting various strategies such as new product launches and approvals, mergers and acquisitions, partnerships and collaborations, and many others to thrive in a competitive environment. For instance, in March 2020, Agilent Technologies has announced the launch of three new microarrays to assist pre-and postnatal research by cytogenetic laboratories. The new Agilent GenetiSure Cyto microarrays include updated, clinically relevant content from respected databases.

The Report Covers

  • Market value data analysis of 2020 and forecast to 2027.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global lab-on-a-chip market based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Lab-on-a-Chip Industry
  • Recovery Scenario of Global Lab-on-a-Chip Industry
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of Covid-19 on Key Players

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Lab-on-a-Chip Market By Product Type
    • 5.1.1. Reagents & Consumable
    • 5.1.2. Instruments
  • 5.2. Global Lab-on-a-Chip Market By Application
    • 5.2.1. Genomics
    • 5.2.2. Proteomics
    • 5.2.3. Diagnostics
    • 5.2.4. Drug Discovery
  • 5.3. Global Lab-on-a-Chip Market By Technology
    • 5.3.1. DNA Microarrays
    • 5.3.2. Microfluidic Chip
  • 5.4. Global Lab-on-a-Chip Market By End User
    • 5.4.1. Hospitals and Diagnostic Labs
    • 5.4.2. Pharmaceutical Companies
    • 5.4.3. Individuals

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. 1DROP Diagnostics
  • 7.2. Abbott Laboratories
  • 7.3. Adhesives Research, Inc.
  • 7.4. Agilent Technologies, Inc.
  • 7.5. Axxicon Moulds Eindhoven B.V.
  • 7.6. BioFluidix GmbH
  • 7.7. BioForce Nanosciences, Inc.
  • 7.8. Bio-Rad Laboratories, Inc.
  • 7.9. BluSense Diagnostics, Inc.
  • 7.10. Beckman Coulter, Inc. (CytoFluidix)
  • 7.11. Danaher Corp.
  • 7.12. F. Hoffmann-La Roche AG
  • 7.13. Fluidigm Corp.
  • 7.14. Fluxion Biosciences, Inc.
  • 7.15. Genalyte, Inc.
  • 7.16. HiComp Microtech (Suzhou) Co. Ltd.
  • 7.17. IDEX Corp.
  • 7.18. Illumina, Inc
  • 7.19. LabSmith, Inc.
  • 7.20. Micralyne, Inc.
  • 7.21. PerkinElmer Inc.
  • 7.22. RheoSense, Inc.
  • 7.23. Siemens Healthcare GmbH
  • 7.24. Syrris Ltd.
  • 7.25. Thermo Fisher Scientific Inc.
  • 7.26. ZenLeads, Inc.
  • 7.27. Zepto Life Technology, LLC